SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-12-008845
Filing Date
2012-02-14
Accepted
2012-02-14 16:33:29
Documents
2
Group Members
D. E. SHAW & CO., L.P., DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G v302142_sc13ga.htm SC 13G/A 57330
2 EXHIBIT 1 v302142_ex-1.htm EX-1 6010
  Complete submission text file 0001144204-12-008845.txt   64976
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 973-290-6000
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60201 | Film No.: 12610607
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036 (212) 478-0000
D. E. Shaw Valence Portfolios, L.L.C. (Filed by) CIK: 0001294704 (see all company filings)

IRS No.: 134046559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A